Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roelf Valkema

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2012
Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementiaWang Zheng Chiu, Janne M Papma, Inge de Koning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogsDik J Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, et al.
The American Journal of Cardiology|February 15, 2003
Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac eventsArend F L Schinkel, Abdou Elhendy, Ron T van Domburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2003
Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viabilityArend F L Schinkel, Jeroen J Bax, Roelf Valkema, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotateRoelf Valkema, Stanislas A Pauwels, Larry K Kvols, et al.
The American Journal of Cardiology|December 27, 2005
Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularizationArend F L Schinkel, Abdou Elhendy, Jeroen J Bax, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 17, 2010
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?Gerrit L ten Kate, Eric J G Sijbrands, Roelf Valkema, et al.
The American Journal of Medicine|June 24, 2004
Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise testsArend F L Schinkel, Jeroen J Bax, Abdou Elhendy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2003
86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusionFrançois Jamar, Raffaella Barone, Isabelle Mathieu, et al.
The American Journal of Cardiology|September 16, 2003
Relation between QT dispersion and myocardial viability in ischemic cardiomyopathyArend F L Schinkel, Manolis Bountioukos, Don Poldermans, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2012
Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementiaWang Zheng Chiu, Janne M Papma, Inge de Koning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogsDik J Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, et al.
The American Journal of Cardiology|February 15, 2003
Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac eventsArend F L Schinkel, Abdou Elhendy, Ron T van Domburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2003
Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viabilityArend F L Schinkel, Jeroen J Bax, Roelf Valkema, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotateRoelf Valkema, Stanislas A Pauwels, Larry K Kvols, et al.
The American Journal of Cardiology|December 27, 2005
Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularizationArend F L Schinkel, Abdou Elhendy, Jeroen J Bax, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 17, 2010
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?Gerrit L ten Kate, Eric J G Sijbrands, Roelf Valkema, et al.
The American Journal of Medicine|June 24, 2004
Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise testsArend F L Schinkel, Jeroen J Bax, Abdou Elhendy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2003
86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusionFrançois Jamar, Raffaella Barone, Isabelle Mathieu, et al.
The American Journal of Cardiology|September 16, 2003
Relation between QT dispersion and myocardial viability in ischemic cardiomyopathyArend F L Schinkel, Manolis Bountioukos, Don Poldermans, et al.
Pageof 10